• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13D/A filed by FOXO Technologies Inc.

    7/24/24 4:00:04 PM ET
    $FOXO
    Life Insurance
    Finance
    Get the next $FOXO alert in real time by email
    SC 13D/A 1 ea020988405-13da2white_foxo.htm AMENDMENT NO. 2 TO SCHEDULE 13D

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION,
    Washington, D.C. 20549

     

    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 2)*

     

    FOXO Technologies Inc.
    (Name of Issuer)

     

    Class A Common stock, par value $0.0001 per share
    (Title of Class of Securities)

     

    351471305
    (CUSIP Number)

     

    Mark Brian White

    9 King George V Place

    Winchester, UK SO22 SFU

    44 7973 802488

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

     

    July 22, 2024
    (Date of Event Which Requires Filing of This Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. ☐

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     
    CUSIP No. 351471305
    (1)

    Names of reporting persons

     

      Mark Brian White
    (2) Check the appropriate box if a member of a group (see instructions)
      (a) ☐
      (b) ☐
    (3)

    SEC use only

     

       
    (4)

    Source of funds (see instructions)

     

     
    (5)

    Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

       
    (6)

    Citizenship or place of organization

     

      United Kingdom

    Number of
    shares
    beneficially
    owned
    by each
    reporting
    person
    with:
    (7)

    Sole voting power

     

    (8)

    Shared voting power

     

    0 (1)

    (9)

    Sole dispositive power

     

    (10)

    Shared dispositive power

     

    0 (1)

    (11)

    Aggregate amount beneficially owned by each reporting person

     

      0 (1)
    (12)

    Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

     

      ☐
    (13)

    Percent of class represented by amount in Row (11)

     

      0 (1)
    (14)

    Type of reporting person (see instructions)

     

      IN

     

    (1)Gives no effect to shares which may be issued to Kr8 ai Inc., of which the Reporting Person is an officer, director and shareholder as consideration for rights granted and services to be rendered pursuant to the Master Software and Services Agreement between Kr8 ai Inc. and the Issuer. The terms of the Master Software and Services Agreement provide for the issuance of additional shares to Kr8 ai Inc. on terms and conditions set forth therein.

     

    2

     

    ITEM 1. SECURITY AND ISSUER.

     

    This Amendment No. 2 to the Statement of Beneficial Ownership filed on February 2, 2024 (the “Statement”), relates to the Class A common stock of FOXO Technologies Inc. (“Issuer”) and is being filed to reflect the fact that on July 22, 2024, in a private transaction, KR8 ai Inc. transferred 1,300,000 shares of the Class A common stock of the Issuer.

     

    ITEM 2. IDENTITY AND BACKGROUND.

     

    The information set forth in Item 2 of the Statement is incorporated herein by reference in response to the requirements of Item 2 of Schedule 13D.  

     

    ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

     

    Not applicable.

     

    ITEM 4. PURPOSE OF TRANSACTION.

     

    Not applicable.

     

    ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.

     

      (a) See rows (11) and (13) of the cover page to this Statement for the aggregate number of shares of Class A common stock and percentage of Class A common stock of the Issuer owned by the Reporting Person as of the date hereof.

     

      (b) See rows (7) through (10) of the cover page to this Amendment for the number of shares of Class A common stock as to which the Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition as of the date hereof.

     

      (c) During the past sixty days, except for the sale of the shares reported in this Amendment, the Reporting Person has not effected any transactions in the Issuer’s Common Stock.

     

      (d) To the best knowledge of the Reporting Person, except as to the securities owned by Kr8 ai Inc., no other person has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities beneficially owned by the Reporting Person.

     

      (e) Not applicable.

     

    ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER.

     

    The information set forth in Item 6 of the Statement is incorporated herein by reference in response to the requirements of Item 6 of Schedule 13D.

     

    ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.

     

    Not applicable.

     

    3

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

      Date July 23, 2024
         
      Signature /s/ Mark Brian White
      Name/Title    Mark Brian White

     

     

    4

     

     

     

     

     

    Get the next $FOXO alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FOXO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $FOXO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Langley Trevor claimed ownership of 1,023,629 shares (SEC Form 3)

    3 - FOXO TECHNOLOGIES INC. (0001812360) (Issuer)

    9/12/24 5:28:21 PM ET
    $FOXO
    Life Insurance
    Finance

    New insider Lagan Seamus claimed ownership of 1,023,629 shares (SEC Form 3)

    3 - FOXO TECHNOLOGIES INC. (0001812360) (Issuer)

    9/12/24 5:27:29 PM ET
    $FOXO
    Life Insurance
    Finance

    Large owner Kr8 Ai Inc. sold $325,000 worth of shares (1,300,000 units at $0.25), closing all direct ownership in the company (SEC Form 4)

    4 - FOXO TECHNOLOGIES INC. (0001812360) (Issuer)

    7/24/24 4:00:23 PM ET
    $FOXO
    Life Insurance
    Finance

    $FOXO
    Leadership Updates

    Live Leadership Updates

    View All

    FOXO TECHNOLOGIES INC.'S BIG SOUTH FORK MEDICAL CENTER COMPLETES PERFORMANCE NETWORK AGREEMENT WITH COVENANT HEALTH TO PROVIDE SWING BED SERVICES

    WEST PALM BEACH, FLORIDA, Aug. 01, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE:FOXO) ("FOXO" or the "Company") today announced that its critical access designated rural hospital, Big South Fork Medical Center located in Oneida, Tennessee, has completed a Performance Network Agreement with Covenant Health to join their performance network as a provider of swing bed services. Covenant Health is a large, muti-facility hospital network serving greater Knoxville and East Tennessee. Patients who no longer meet acute care admission criteria are frequently in need of post-acute care to enhance their recovery. Big South Fork Medical Center is well positioned to provide swing bed services

    8/1/25 7:52:00 AM ET
    $FOXO
    Life Insurance
    Finance

    FOXO TECHNOLOGIES INC. CREATES ACQUISITION VEHICLE AND APPOINTS NEW INTERIM CFO

    WEST PALM BEACH, FLORIDA, June 16, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE:FOXO) ("FOXO" or the "Company") today announced that it formed a new, wholly-owned subsidiary intended to be used to acquire identified acquisition targets in the healthcare services and related sectors. On June 13, 2025, the Company formed FOXO Acquisition Corporation, a Florida corporation, for the purpose of acquiring targeted acquisitions. The Company also intends to create a new series of non-convertible preferred stock with a goal to have this preferred stock publicly listed (with its own trading symbol) and use it to as a mechanism to complete such acquisitions. The new series of preferred stoc

    6/16/25 7:43:00 AM ET
    $FOXO
    Life Insurance
    Finance

    FOXO TECHNOLOGIES INC. ANNOUNCES RESTRUCTURING AND CAPITAL RAISING TRANSACTIONS AND APPOINTS SEAMUS LAGAN AS CHIEF EXECUTIVE OFFICER

    MINNEAPOLIS, MN, Dec. 11, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the "Company" or "FOXO") announces a series of restructuring and capital raising transactions which will improve the Company's balance sheet, satisfy minimum stockholders' equity requirements of the NYSE American and provide capital for growth and reduce outstanding liabilities. The Company also announces a change in senior leadership. Key transactions include: Rennova Health, Inc.'s exchange of approximately $21 million of a Senior Secured Note issued by Rennova Community Health, Inc., the Company's subsidiary, into 21,000 shares of the Company's Series A Cumulative Convertible Redeemable Pr

    12/11/24 8:00:00 AM ET
    $FOXO
    Life Insurance
    Finance

    $FOXO
    SEC Filings

    View All

    SEC Form 25-NSE filed by FOXO Technologies Inc.

    25-NSE - FOXO TECHNOLOGIES INC. (0001812360) (Subject)

    8/22/25 11:27:59 AM ET
    $FOXO
    Life Insurance
    Finance

    SEC Form 10-Q filed by FOXO Technologies Inc.

    10-Q - FOXO TECHNOLOGIES INC. (0001812360) (Filer)

    8/19/25 4:01:13 PM ET
    $FOXO
    Life Insurance
    Finance

    Amendment: SEC Form 10-Q/A filed by FOXO Technologies Inc.

    10-Q/A - FOXO TECHNOLOGIES INC. (0001812360) (Filer)

    8/19/25 10:52:54 AM ET
    $FOXO
    Life Insurance
    Finance

    $FOXO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    FOXO TECHNOLOGIES INC. ANNOUNCES THAT ITS COMMON STOCK CAN BE QUOTED AND TRADED ON THE OVER THE COUNTER MARKET FROM AUGUST 13, 2025.

    WEST PALM BEACH, FLORIDA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. ("FOXO" or the "Company") announces that it has received a letter from NYSE on August 12, 2025 confirming that NYSE Regulation has determined to commence proceedings to delist the Class A common stock of FOXO (Ticker symbol FOXO) from NYSE American, pursuant to Section 1003(f)(v) of the NYSE American Company Guide due to the low selling price of the Class A commons stock. The share price went below the NYSE minimum price of $0.10 on August 12, 2025 and was immediately suspended from trading by NYSE. The Company submitted an application to have its common stock traded on the OTC and has on August 12, 2025 re

    8/13/25 7:52:00 AM ET
    $FOXO
    Life Insurance
    Finance

    FOXO TECHNOLOGIES INC. ANNOUNCES EXECUTION OF A NON-BINDING ACQUISITION AGREEMENT FOR AN ASSISTED-LIVING FACILITY IN SOUTH FLORIDA FOR A TOTAL CONSIDERATION OF $22 MILLION

    WEST PALM BEACH, FLORIDA, Aug. 06, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE:FOXO) ("FOXO" or the "Company") announces that it has executed a non-binding acquisition agreement to acquire an assisted living and memory care facility in South Florida. The proposed acquisition includes the land and buildings. The facility has 87 units licensed for the provision of assisted living and memory care services. The purchase price for the facility is expected to be $22 million, a portion of which is milestone-based. $5M of the purchase price will be in the form of non-convertible preferred stock. Completion of the acquisition is subject to definitive agreements and a number of closing co

    8/6/25 7:43:00 AM ET
    $FOXO
    Life Insurance
    Finance

    FOXO TECHNOLOGIES INC.'S BIG SOUTH FORK MEDICAL CENTER COMPLETES PERFORMANCE NETWORK AGREEMENT WITH COVENANT HEALTH TO PROVIDE SWING BED SERVICES

    WEST PALM BEACH, FLORIDA, Aug. 01, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE:FOXO) ("FOXO" or the "Company") today announced that its critical access designated rural hospital, Big South Fork Medical Center located in Oneida, Tennessee, has completed a Performance Network Agreement with Covenant Health to join their performance network as a provider of swing bed services. Covenant Health is a large, muti-facility hospital network serving greater Knoxville and East Tennessee. Patients who no longer meet acute care admission criteria are frequently in need of post-acute care to enhance their recovery. Big South Fork Medical Center is well positioned to provide swing bed services

    8/1/25 7:52:00 AM ET
    $FOXO
    Life Insurance
    Finance

    $FOXO
    Financials

    Live finance-specific insights

    View All

    FOXO TECHNOLOGIES INC. DESIGNATES NEW SERIES OF PREFERRED STOCK TO BE USED FOR ACQUISITIONS

    WEST PALM BEACH, FLORIDA, June 27, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE:FOXO) ("FOXO" or the "Company") today announced that it has designated a new series of its preferred stock (Series E Cumulative Redeemable Secured Preferred Stock e (the "Series E Preferred Stock")) and filed the series' certificate of designation with the Secretary of State of Delaware. The newly designated series of preferred stock includes: (i) a stated value of $25.00 per share, (ii) a 2.5% per annum cash dividend paid semi-annually, (iii) a 5.0% per annum common stock dividend paid semi-annually, and (iv) a security interest in the stock of the Company's recently formed acquisition vehicle, FOXO A

    6/27/25 7:27:00 AM ET
    $FOXO
    Life Insurance
    Finance

    FOXO TECHNOLOGIES, INC., PROVIDES UPDATE ON RECENT ACOMPLISHMENTS AND BUSINESS STRATEGY

    MINNEAPOLIS, MN, Jan. 28, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the "Company"), provides a brief shareholder letter from Seamus Lagan, recently appointed CEO of FOXO on what has been achieved in recent months and what is planned for 2025 and beyond. Dear Fellow Shareholders, Our recent shareholders meeting on January 17th concluded the requirements of 2024 acquisition agreements and resulted in a change of control of the Company. The accomplishments in the second half of 2024 have been key to what we believe is becoming a very successful turnaround of our Company and has created a foundation from which we believe we can build a significant and profitable

    1/28/25 8:05:00 AM ET
    $FOXO
    Life Insurance
    Finance

    FOXO TECHNOLOGIES INC., PROVIDES UPDATE ON 2024 ACCOMPLISHMENTS AND PLANS FOR REMAINDER OF THE YEAR

    MINNEAPOLIS, MN, Oct. 15, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the "Company" or "FOXO"), provides a shareholder letter from Mark White, Interim CEO of FOXO, on what has been achieved in 2024 and what is planned for the remainder of 2024 and beyond. Dear Fellow Shareholders, 2024 has been an exciting, tumultuous and productive year for us. We believe the accomplishments already completed and that we believe will be achieved before year-end create a foundation from which we can build a successful enterprise that will increase shareholder value. The Company began 2024 with a continued focus on commercializing its epigenetic technology while, at the same ti

    10/15/24 8:30:00 AM ET
    $FOXO
    Life Insurance
    Finance

    $FOXO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by FOXO Technologies Inc.

    SC 13G/A - FOXO TECHNOLOGIES INC. (0001812360) (Subject)

    11/7/24 8:46:01 AM ET
    $FOXO
    Life Insurance
    Finance

    Amendment: SEC Form SC 13D/A filed by FOXO Technologies Inc.

    SC 13D/A - FOXO TECHNOLOGIES INC. (0001812360) (Subject)

    9/23/24 4:15:07 PM ET
    $FOXO
    Life Insurance
    Finance

    SEC Form SC 13D filed by FOXO Technologies Inc.

    SC 13D - FOXO TECHNOLOGIES INC. (0001812360) (Subject)

    8/5/24 4:15:29 PM ET
    $FOXO
    Life Insurance
    Finance